diffuse hemispheric glioma
Novartis’ Kisqali recommended by NICE to treat broad early breast cancer population
The drug was previously available only for patients whose cancer had spread to nearby lymph nodes
Novartis’ Kisqali granted MHRA approval to treat early breast cancer patients
The drug is already approved in the UK to treat advanced cases of the disease
ICR researchers uncover genes responsible for tumour progression in prostate cancer
The findings could pave the way for new treatment approaches that improve patient outcomes
ICR study reveals how PARP inhibitor resistance develops in prostate cancer patients
The research could pave the way for the development of new drugs that prevent drug resistance
Novartis’ Kisqali receives EC approval to treat early breast cancer patients
Approximately 70% of breast cancer cases are diagnosed in the early stages of the disease
ICR researchers identify potential treatment approach for acute myeloid leukaemia
More than 3,100 people are diagnosed with the aggressive blood cancer in the UK every year
Novartis’ Kisqali receives CHMP recommendation for early breast cancer patients
Approximately 70% of all breast cancer patients have HR-positive/HER2-negative disease
ICR researchers reveal benefits of personalised radiotherapy for bladder cancer patients
More than 130,000 patients are treated with radiotherapy on the NHS every year
ICR researchers identify new drug target for advanced prostate cancer patients
The team estimates that around 10% of patients have high levels of the BCL2 protein
Novartis’ Kisqali combination granted FDA approval for early breast cancer patients
The drug is already approved for certain cases of advanced or metastatic breast cancer
Breast cancer drug found to help slow growth of rare childhood brain tumour
Researchers discovered that targeting the CDK6 protein could make tumour cells vulnerable to treatment
UK study reveals previously unknown genetic causes of colorectal cancer
The third most commonly diagnosed cancer globally is responsible for more than 44,000 new cases in the UK every year